Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria

Malarial hepatopathy: Clinical profile and association with other malarial complications

(2016) Anshika Jain et al.   ACTA TROPICA

Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection

(2015) Erwan Thouennon et al.   JOURNAL OF NEUROCHEMISTRY

Malaria-associated hypoglycaemia in children

(2014) Lola Madrid et al.   Expert Review of Anti-Infective Therapy

Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone

(2014) Y Cheng et al.   MOLECULAR PSYCHIATRY

PPARγ Agonists Improve Survival and Neurocognitive Outcomes in Experimental Cerebral Malaria and Induce Neuroprotective Pathways in Human Malaria

(2014) Lena Serghides et al.   PLoS Pathogens

Profile: Manhica Health Research Centre (Manhica HDSS)

(2013) C. Sacoor et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease

(2013) Jing Jin et al.   JOURNAL OF NEUROCHEMISTRY

The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience

(2013) William R. Hiatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 'hidden' burden of malaria: cognitive impairment following infection

(2011) Sumadhya D Fernando et al.   MALARIA JOURNAL

Early Life Programming and Neurodevelopmental Disorders

(2010) Tracy L. Bale et al.   BIOLOGICAL PSYCHIATRY

Adjunctive therapy for cerebral malaria and other severe forms ofPlasmodium falciparummalaria

(2010) Chandy C John et al.   Expert Review of Anti-Infective Therapy

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

(2010) Arjen M Dondorp et al.   LANCET

Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study

(2010) Gretchen L Birbeck et al.   LANCET NEUROLOGY

Use of Peroxisome Proliferator‐Activated Receptor γ Agonists as Adjunctive Treatment forPlasmodium falciparumMalaria: A Randomized, Double‐Blind, Placebo‐Controlled Trial

(2009) Andrea K. Boggild et al.   CLINICAL INFECTIOUS DISEASES

Rosiglitazone Modulates the Innate Immune Response toPlasmodium falciparumInfection and Improves Outcome in Experimental Cerebral Malaria

(2009) Lena Serghides et al.   JOURNAL OF INFECTIOUS DISEASES

Impaired everyday memory associated with encephalopathy of severe malaria: the role of seizures and hippocampal damage

(2009) Michael Kihara et al.   MALARIA JOURNAL

Malaria in rural Mozambique. Part II: children admitted to hospital

(2008) Quique Bassat et al.   MALARIA JOURNAL

Cerebral Malaria in Children Is Associated With Long-term Cognitive Impairment

(2008) C. C. John et al.   PEDIATRICS

Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists

(2007) Ramya Kapadia   Frontiers in Bioscience-Landmark